Resveratrol
Resveratrol (3,5,4′-trihydroxy-trans-stilbene) is a stilbenoid, a type of natural phenol or polyphenol and a phytoalexin produced by several plants in response to injury or when the plant is under attack by pathogens, such as bacteria or…
≈ 4 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Resveratrol (3,5,4′-trihydroxy-trans-stilbene) is a stilbenoid, a type of natural phenol or polyphenol and a phytoalexin produced by several plants in response to injury or when the plant is under attack by pathogens, such as bacteria or fungi. Sources of resveratrol in food include the skin of grapes, blueberries, raspberries, mulberries, and peanuts.
Although commonly used as a dietary supplement and studied in laboratory models of human diseases, there is no high-quality evidence that resveratrol improves lifespan or has a substantial positive effect on any human disease. In particular, its effect on cancer prevention is so slight that drinking red wine for the sake of consuming resveratrol causes 100,000 alcohol-induced cancers for each single case of cancer that might be prevented by the resveratrol in the wine.
Research
Resveratrol has been studied for its potential therapeutic use, with little evidence of anti-disease effects or health benefits in humans.
Cardiovascular disease
Resveratrol supplementation does not affect biomarkers for cardiovascular diseases. There is no evidence of benefit from resveratrol in people who already have heart disease.
A 2018 meta-analysis found no effect on systolic or diastolic blood pressure; a sub-analysis revealed a 2 mmHg decrease in systolic pressure only from resveratrol doses of 300 mg per day, and only in diabetic people. A 2014 Chinese meta-analysis found no effect on systolic or diastolic blood pressure; a sub-analysis found an 11.90 mmHg reduction in systolic blood pressure from resveratrol doses of 150 mg per day.
Cancer
, there is no evidence of an effect of resveratrol on cancer in humans.
Metabolic syndrome
There is no conclusive evidence for an effect of resveratrol on human metabolic syndrome. One 2015 review found little evidence for use of resveratrol to treat diabetes. Meta-analyses in 2021 and 2015 found little evidence for an effect of resveratrol on diabetes biomarkers.
One review found limited evidence that resveratrol lowered fasting plasma glucose in people with diabetes. Two reviews indicated that resveratrol supplementation may reduce body weight and body mass index, but not fat mass or total blood cholesterol.
A 2018 review found some evidence that resveratrol supplementation could reduce biomarkers of inflammation, TNF-α and C-reactive protein, while a 2015 review reported no evidence for effects of resveratrol on biomarkers of inflammation or cardiovascular diseases.
Lifespan
, there is insufficient evidence to indicate that consuming resveratrol has an effect on human lifespan.
Cognition
Resveratrol has been assessed for a possible effect on cognition, but with mixed evidence for an effect. One review concluded that resveratrol had no effect on neurological function, but reported that supplementation improved recognition and mood, although there were inconsistencies in study designs and results.
Alzheimer's disease
A 2022 meta-analysis provided preliminary evidence that resveratrol, alone or in combination with glucose and malate, may slow cognitive decline in Alzheimer's disease.
Diabetes
Research on people with diabetes is limited and does not support the use of resveratrol for this purpose.
Other
There is no significant evidence that resveratrol affects vascular endothelial function, neuroinflammation, skin infections or aging skin. A 2019 review of human studies found mixed effects of resveratrol on certain bone biomarkers, such as increases in blood and bone alkaline phosphatase, while reporting no effect on other biomarkers, such as calcium and collagen.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1356674888 under CC BY-SA 4.0; modifications have been made.